Cargando…
Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer
PURPOSE: To analyze the plasma lipid spectrum between healthy control and patients with pancreatic cancer and to select differentially expressed tumor markers for early diagnosis. METHODS: In total, 20 patents were divided into case group and healthy control group according to surgical pathology. Of...
Autores principales: | Zhou, Dehua, Mu, Di, Cheng, Ming, Dou, Yuting, Zhang, Xianwei, Feng, Zhensheng, Qiu, Guangting, Yu, Hua, Chen, Yang, Xu, Hong, Sun, Jian, Zhou, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341992/ https://www.ncbi.nlm.nih.gov/pubmed/32638847 http://dx.doi.org/10.1590/s0102-865020200050000008 |
Ejemplares similares
-
Erratum: Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer
Publicado: (2020) -
Investigating the Potential of Lipids for Use as Biomarkers for Glioblastoma via an Untargeted Lipidomics Approach
por: Soylemez, Burcak, et al.
Publicado: (2023) -
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
por: Beyoğlu, Diren, et al.
Publicado: (2020) -
Lipidomics in biomarker development
por: Wenk, Markus
Publicado: (2010) -
Plasma Lipidomics Profiling Reveals Biomarkers for Papillary Thyroid Cancer Diagnosis
por: Jiang, Nan, et al.
Publicado: (2021)